INTERNATIONAL PATENT: SUNGKWANG MEDICAL FOUNDATION, 의료법인 성광의료재단, CHA UNIVERSITY INDUSTRY-ACADEMIC COOPERATION FOUNDATION, 차의과학대학교 산학협력단 FILES APPLICATION FOR "EXTRACELLULAR VESICLES LOADED WITH DRUG TO BE DELIVERED TO RETINA THROUGH TRANSSCLERAL PATHWAY AND COMPOSITION FOR PREVENTING OR TREATING OPTIC NEURODEGENERATIVE DISEASES, COMPRISING SAME"

GENEVA, Oct. 19 -- SUNGKWANG MEDICAL FOUNDATION (566 Nonhyeon-ro,Gangnam-gu,Seoul 06135), 의료법인 성광의료재단 (서울특별시강남구논현로 566), CHA UNIVERSITY INDUSTRY-ACADEMIC COOPERATION FOUNDATION (120 Haeryong-roPocheon-siGyeonggi-do 11160), 차의과학대학교 산학협력단 (경기도포천시해룡로 120) filed a patent application (PCT/KR2025/004842) for "EXTRACELLULAR VESICLES LOADED WITH DRUG TO BE DELIVERED TO RETINA THROUGH TRANSSCLERAL PATHWAY, AND COMPOSITION FOR PREVENTING OR TREATING OPTIC NEUROD...